René Medema
We have been using the complete DNA test for the past two years in the routine care of patients with cancer. The test provides at least as much, and often more, information we can use to treat our patients than regular tests. Moreover, in patients with an unknown primary tumor, it can help us to diagnose the cancer and find a treatment. This test also makes a difference for patients with a sarcoma. Our researchers have scientifically demonstrated this in several studies.
Back to newsMore news
Whole Genome Sequencing for cancer diagnostics clinically validated
Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …
New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS
Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …
Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice
By Laura Nederveen In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …
The complete DNA test provides a complete overview of all potential targeted cancer treatments. The patient and the attending physician have all available information to make a treatment decision.